SEC Info - Kazam Joshua A - ‘5’ for 12/31/20 re: Allogene Therapeutics, Inc.

SEC Info℠

Home

Help

Please Sign In

Kazam Joshua A – ‘5’ for 12/31/20 re: Allogene Therapeutics, Inc.

On: Wednesday, 2/3/21, at 4:22pm ET · For: 12/31/20 · Accession #: 1214659-21-1199 · File #: 1-38693

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/03/21  Kazam Joshua A                    5                      1:5K   Allogene Therapeutics, Inc.       Securex Filings/FA

Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 — SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 5           Annual Statement of Changes in Beneficial           HTML      3K 
                Ownership of Securities by an Insider --                         
                marketforms-51228.xml/3.6

Filing Submission 0001214659-21-001199 – SGML Text

Original SGML Text submitted by:	Securex Filings/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Kazam Joshua A – ‘5’ for 12/31/20 re: Allogene Therapeutics, Inc.

On: Wednesday, 2/3/21, at 4:22pm ET · For: 12/31/20 · Accession #: 1214659-21-1199 · File #: 1-38693

Previous ‘5’: ‘5’ on 2/14/18 for 12/31/17 · Latest ‘5’: This Filing

Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 — SEA’34Filing Table of Contents

To view the SGML, please refresh this page.

Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 — SEA’34
Filing Table of Contents

To view the SGML, please refresh
this page.